Familial Mediterranean fever is a genetic condition that brings unexpected storms of fever and pain, particularly to people whose roots trace back to the shores of the Mediterranean Sea. Though there is no cure, a simple daily medication can help most people live full, active lives.

Understanding Familial Mediterranean Fever

Familial Mediterranean fever, often called FMF, is a hereditary inflammatory disorder that causes the body to experience repeated episodes of fever along with painful inflammation in the abdomen, chest, and joints. The condition gets its name because it primarily affects people whose ancestors came from regions around the Mediterranean Sea. These include individuals of Armenian, Arab, Turkish, Greek, Italian, Jewish, Iranian, and Kurdish descent, though anyone from any ethnic background can develop the condition.^[1][3]

This disorder falls into a category known as autoinflammatory diseases, which are conditions where the immune system mistakenly triggers inflammation without an external threat like an infection. Unlike autoimmune diseases where the immune system attacks the body’s own tissues, autoinflammatory diseases involve a malfunction in the part of the immune system that responds to immediate threats. FMF specifically affects certain membranes in the body called serous membranes, which line the abdomen, chest, and joints, as well as synovial membranes that surround joints.^[3]

The condition typically reveals itself during childhood, with most people experiencing their first attack before reaching twenty years of age. In fact, about seventy-five percent of FMF cases begin before age ten, and ninety percent start before age twenty.^[7] These attacks come in episodes that develop over several hours and usually last between one and three days, though joint attacks can sometimes persist for weeks or months.^[1]

How Common Is Familial Mediterranean Fever

The frequency of familial Mediterranean fever varies dramatically depending on a person’s ethnic background. Among certain Mediterranean and Middle Eastern populations, FMF is remarkably common. In these high-risk groups, the condition affects anywhere from one in two hundred to one in one thousand people.^[6] This represents a significant portion of these populations, making FMF one of the most common inherited inflammatory conditions in these communities.

Armenian populations show particularly high rates of FMF, as do people of Turkish, Arab, and Jewish descent, whether Sephardic, Mizrahi, or Ashkenazi. Greeks, Iranians, Kurds, and Italians also have elevated rates compared to other populations.^[5] Interestingly, somewhat higher rates have also been observed in certain Asian populations, which was unexpected given the condition’s name and traditional association with Mediterranean peoples.^[15]

Outside these high-frequency populations, FMF occurs much less commonly. However, because people of Mediterranean and Middle Eastern heritage have migrated worldwide over generations, cases can appear in any geographic location. Specialized clinics have emerged in areas with significant populations from these regions. For instance, UCLA’s FMF Program, established in the early 1960s, has registered more than seven hundred patients and serves as an important referral center for diagnoses and treatment in the Western Hemisphere.^[4]

What Causes Familial Mediterranean Fever

Familial Mediterranean fever results from variations in a specific gene called MEFV, which stands for Mediterranean fever. This gene is located on the short arm of chromosome sixteen. The MEFV gene contains instructions for making a protein called pyrin, also known as marenostrin, which plays a crucial role in regulating inflammation in the body. The pyrin protein is found in white blood cells and helps the immune system control when and how strongly inflammatory responses occur.^[2][6]

When mutations occur in the MEFV gene, the resulting pyrin protein doesn’t function properly. This malfunction disrupts the body’s ability to regulate inflammation, leading to inappropriate or prolonged inflammatory responses. Essentially, the broken protein fails to properly turn off inflammation once it starts, causing the fever and pain that characterize FMF attacks.^[3][6]

Scientists have identified around three hundred different mutations in the MEFV gene that can lead to FMF, though these mutations commonly occur in specific regions of the gene known as exons two, three, five, and ten. Among all these variations, five particular mutations are responsible for seventy to eighty percent of FMF cases. These are designated by scientific codes: V726A, M680I, E148Q, M694V, and M694I. These most common mutations are found predominantly in Mediterranean and Middle Eastern populations.^[2][3]

Researchers believe that MEFV gene mutations might also play a role in other autoimmune and inflammatory diseases, including rheumatoid arthritis, suggesting that the gene’s influence extends beyond FMF alone.^[13]

How Familial Mediterranean Fever Is Inherited

FMF is usually inherited in an autosomal recessive pattern, which means a person must inherit two copies of the mutated gene—one from each parent—to develop the condition. Parents who each carry one copy of a mutated MEFV gene typically show no signs of the disease themselves. When both parents are carriers, there is a one-in-four chance with each pregnancy that their child will inherit both mutated genes and develop FMF. This explains why the condition is called “familial”—it runs in families.^[4][6]

In rare cases, FMF appears to follow an autosomal dominant pattern, where having just one copy of the mutated gene is sufficient to cause symptoms. However, the mechanisms behind these cases are still being investigated.^[6] Interestingly, about one-third of people diagnosed with FMF have only one identifiable MEFV gene variant, though experts believe there is likely a second variant elsewhere in the gene that current genetic testing hasn’t detected.^[6]

Additionally, about ten percent of patients who are diagnosed clinically with FMF based on their symptoms have no detectable mutations in the MEFV gene at all. This highlights that genetic testing, while helpful, isn’t perfect, and diagnosis often relies on a combination of genetic results, family history, and clinical symptoms.^[2]

Risk Factors for Developing Familial Mediterranean Fever

The primary risk factor for developing FMF is having ancestors from Mediterranean or Middle Eastern regions. This includes people of Armenian, Turkish, Arab, Jewish, Greek, Italian, Iranian, and Kurdish heritage. Even individuals who are several generations removed from these regions may carry the genetic mutations that cause FMF.^[5][13]

Family history represents another significant risk factor. If close relatives—parents, siblings, or children—have been diagnosed with FMF, other family members have a higher likelihood of carrying the genetic mutations. First-degree relatives of someone with FMF may benefit from genetic testing and monitoring, even if they haven’t experienced symptoms.^[4]

The age at which FMF develops is fairly predictable. Most people who will develop the condition experience their first attack during childhood or adolescence. If someone from a high-risk population hasn’t experienced symptoms by their early twenties, they are less likely to develop FMF later in life, though late-onset cases do occasionally occur.^[2][7]

There don’t appear to be clear gender differences in who develops FMF. The condition affects males and females equally, though some symptoms like scrotal inflammation naturally affect only males, and some women report that attacks coincide with menstruation or ovulation.^[3]

Symptoms of Familial Mediterranean Fever

The hallmark of familial Mediterranean fever is recurring episodes—called attacks—of fever and pain. Not everyone experiences every symptom, and the specific combination and severity of symptoms can vary considerably from person to person, even among family members with the condition.^[13]

Fever is the most common symptom and may be the only symptom in young children under five years old. During an attack, body temperature can climb dramatically, reaching up to one hundred five degrees Fahrenheit or forty point six degrees Celsius. The fever often comes with chills and can make a person feel extremely unwell.^[3][7]

Abdominal pain affects about ninety-five percent of all FMF patients and can be severe enough to mimic surgical emergencies like appendicitis. The pain involves the entire abdomen with signs of peritonitis, which is inflammation of the membrane lining the abdominal cavity. The abdomen may become swollen and distended, and the muscles can become rigid. This sometimes leads to unnecessary surgical procedures before the correct diagnosis is made. Some people also experience constipation during attacks.^[1][5]

Chest pain occurs in about forty percent of patients and results from pleuritis, which is inflammation of the membrane surrounding the lungs. This pain often worsens with breathing and can make it difficult to take deep breaths or lie flat. Less commonly, inflammation of the pericardium—the sac surrounding the heart—can occur, though this is rare.^[5]

Joint involvement happens in seventy-five percent of FMF patients. Usually, only one large joint is affected at a time, most commonly the knees, ankles, or hips. The joint becomes painful and swollen, and while most joint attacks resolve within days like other FMF symptoms, some can last for weeks or even months before completely resolving.^[1][5]

About one-third of patients develop a distinctive red, raised rash, typically on the lower legs, especially below the knees. This rash can sometimes be mistaken for cellulitis, a bacterial skin infection.^[5][7]

Muscle pain, particularly in the lower legs and often triggered by physical activity, affects some people with FMF. Males may experience scrotal swelling and pain in the testicles, which can be mistaken for testicular torsion, a surgical emergency.^[1][5]

Headaches, sometimes accompanied by neck stiffness, can occur during attacks. Rare complications include inflammation of the heart muscle, the membranes around the brain and spinal cord, or the muscles throughout the body.^[3][7]

Some people experience warning signs in the days leading up to an attack. These prodromal symptoms are similar to what some people feel before a migraine headache or menstrual period. They can include anxiety, irritability, headache, nausea, general body aches, and a feeling of being generally unwell. Recognizing these warning signs can help people prepare for an upcoming attack.^[3]

Between attacks, people with FMF typically feel completely normal and healthy. These symptom-free periods can be as short as a few days or as long as several years. The unpredictability of when attacks will occur is one of the challenging aspects of living with FMF.^[1]

Triggers That May Spark an Attack

While FMF attacks often seem to occur randomly without an obvious cause, many people with the condition identify certain triggers that appear to bring on episodes. Understanding these triggers can sometimes help people avoid situations that might lead to an attack, though it isn’t always possible to prevent them completely.^[3]

Physical stress on the body frequently precedes attacks. This can include exposure to cold temperatures, strenuous exercise or physical exertion, and recent infections. Even minor infections like a cold can trigger an FMF episode. Recent injury or surgery also commonly precipitates attacks, which is important for healthcare providers to know when planning procedures for people with FMF.^[3]

Emotional and psychological stress appears to trigger attacks in some individuals. Severe life stress, major life changes, or periods of intense emotional difficulty may increase the likelihood of experiencing an episode. For women, hormonal changes related to menstruation or ovulation can trigger attacks, with some women noticing a consistent pattern of symptoms occurring at specific points in their menstrual cycle.^[3][6]

Preventing Familial Mediterranean Fever

Because FMF is a genetic condition present from birth, there is no way to prevent the disease itself from developing in someone who has inherited the genetic mutations. However, for families where FMF is known to run, genetic counseling before having children can help parents understand the risks and make informed decisions. Genetic testing can identify whether someone is a carrier of MEFV mutations, which is particularly valuable information for people from high-risk populations who are planning families.^[4][13]

While the disease itself cannot be prevented, preventing attacks and complications once someone has FMF is highly achievable. Daily medication with a drug called colchicine prevents or dramatically reduces the frequency and severity of attacks in more than ninety percent of people with FMF. Taking this medication consistently, without skipping doses, is the most effective way to prevent the painful episodes that characterize the condition.^[8][10]

Preventing the most serious complication of FMF—amyloidosis, which involves protein deposits building up in organs and potentially causing kidney failure—requires early diagnosis and consistent treatment. People from populations at particularly high risk for amyloidosis, such as those of North African Jewish, Turkish, or Armenian descent living in Armenia, should maintain daily colchicine therapy to prevent this life-threatening complication.^[10]

Even people with mild or infrequent symptoms should have their urine checked for protein every six months, as protein in the urine can be an early warning sign of kidney damage from amyloidosis. This regular monitoring allows healthcare providers to detect problems early when they’re most treatable.^[13]

Avoiding known personal triggers when possible may help reduce attack frequency, though this isn’t always practical or entirely effective. Maintaining overall good health through adequate rest, stress management, and avoiding extreme physical demands might help some people, though the evidence for lifestyle modifications is limited compared to the clear benefit of medication.^[13]

How Familial Mediterranean Fever Affects the Body

Understanding how FMF changes normal body function helps explain both the symptoms people experience and why treatment works. At the cellular level, the condition involves a malfunction in how the immune system regulates inflammation. The pyrin protein, which is defective in people with FMF, normally acts like a brake on inflammatory processes, helping to shut down inflammation once it’s no longer needed. When pyrin doesn’t work properly, the inflammatory response becomes dysregulated—it starts inappropriately and continues longer than it should.^[2][4]

During an FMF attack, white blood cells release inflammatory signals that cause blood vessels to dilate and become leaky, allowing fluid and more immune cells to flood into tissues. This creates the swelling, pain, heat, and redness characteristic of inflammation. When this happens in the membranes lining the abdomen, it causes peritonitis and severe abdominal pain. When it occurs in the pleura surrounding the lungs, it creates chest pain. In joints, it produces arthritis with pain and swelling.^[4]

The fever that accompanies attacks results from inflammatory chemicals affecting the hypothalamus, the part of the brain that regulates body temperature. These chemicals essentially reset the body’s thermostat to a higher temperature, causing the dramatic fevers seen in FMF. The body responds by generating heat through shivering and by conserving heat, which is why people often feel cold and have chills even as their temperature climbs.^[3]

Between attacks, the inflammatory process quiets down and the body returns to normal function. This is why people feel completely healthy between episodes. However, even during symptom-free periods, there may be low levels of inflammation continuing in the body that aren’t noticeable but can, over time, lead to the accumulation of abnormal proteins.^[1]

The most serious long-term consequence of repeated inflammatory episodes is the development of amyloidosis. During attacks, the liver produces large quantities of a protein called amyloid A as part of the inflammatory response. In people with untreated or poorly controlled FMF, these proteins can accumulate and form deposits in organs and tissues throughout the body. The kidneys are particularly vulnerable to these deposits, which interfere with normal kidney function and can eventually lead to kidney failure. This is why preventing attacks through medication is so crucial—it prevents not just the immediate pain of attacks but also this potentially fatal long-term complication.^[5][9]